Entelevest’s Abbott ABT Stock Holding History

Entelevest’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,694	Closed	-$212K	–	139
2025 Q4	$212K	Buy	+1,694	New	+$216K	0.21%	104

Other funds holding ABT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Entelevest's ABT Position: Q1 2026 in Review

Entelevest sold out of Abbott (ABT) in Q1 2026, closing a stake of 1,694 shares — an estimated $212K sold.

Entelevest first reported a position in ABT in Q4 2025 and held it in 1 quarter. The position peaked at $212K in Q4 2025. 3,116 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

Entelevest reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
Entelevest sold 1,694 Abbott shares in Q1 2026, an estimated $212K.
Entelevest first reported a position in Abbott in Q4 2025 and held it in 1 quarter.
Entelevest's Abbott position peaked at $212K in Q4 2025.
3,116 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Entelevest's 13F filing for Q1 2026, filed 5 May 2026.